Aflac Incorporated (AFL) Stock Analysis
Latest ClaritX AI analysis ·
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disa
| Metric | Value |
|---|---|
| Price | $113.63 |
| Market cap | $57.8B |
| Sector | Financial Services |
| Industry | Insurance - Life |
| ClaritX AI score | 69/100 |
| Price/Book | 1.89 |
| Dividend yield | 2.12% |
| Beta | 0.56 |
AI verdict
Aflac Incorporated (NYSE: AFL) remains an immaculate, cash-rich financial fortress that is beginning to exhibit early signs of technical stabilization following a period of severe structural distribution. At its current trading price of $113.63, the equity is positioned $16.59, or exactly 12.74%, below its established 52-week high of $130.22. It is mathematically critical to evaluate this steep retracement strictly through the lens of the asset's exceptionally low beta of 0.556. Unlike highly speculative, high-beta equities where trading near highs implies euphoric momentum and deep pullbacks are standard, a deeply defensive, ultra-low volatility stock like Aflac experiencing a near-13% drawdown provides a mathematically profound margin of safety for strict value investors. Crucially, the RSI has recovered from the deep low-20s to 33.37, indicating that the heaviest algorithmic selling pressure is exhausted, though the stock must still reclaim its 200-day SMA ($115.07) to confirm a new bull phase. Fundamentally, Aflac operates with a towering 26.88% net profit margin, an elite 24.56% dividend payout ratio, and an astonishing $185.77 per share in statutory liquid assets. The stock trades at a deeply discounted trailing P/E ratio of 12.19, rendering it fundamentally de-risked from a valuation standpoint. While continuous structural liquidation by major legacy stakeholders (notably Post Holdings) creates a massive supply ceiling, the revelation of a $244.5 million accumulation
What this score has been worth
ClaritX scores AFL 69 out of 100 (snapshot 2026-10-15).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 212 analyses that scored in the 50-69 band, the average forward return was -6.3% with a 37% win rate, -10.5pp against the S&P 500. That is a measured tendency across many names, not a forecast for AFL — roughly 63% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.